Join

Compare · AXDX vs BRKR

AXDX vs BRKR

Side-by-side comparison of Accelerate Diagnostics Inc. (AXDX) and Bruker Corporation (BRKR): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both AXDX and BRKR operate in Biotechnology: Laboratory Analytical Instruments (Industrials), so they compete in similar markets.
  • BRKR is the larger of the two at $9.81B, about 49.8x AXDX ($197.2M).
  • Over the past year, AXDX is down 93.2% and BRKR is down 7.9% - BRKR leads by 85.3 points.
  • BRKR has hit the wire 11 times in the past 4 weeks while AXDX has been quiet.
  • BRKR has more recent analyst coverage (21 ratings vs 1 for AXDX).
PerformanceAXDX-93.21%BRKR-4.46%
2025-04-28+0.00%2025-05-14
MetricAXDXBRKR
Company
Accelerate Diagnostics Inc.
Bruker Corporation
Price
$0.14+59.82%
$36.55+0.74%
Market cap
$197.2M
$9.81B
1M return
-93.21%
+2.11%
1Y return
-93.21%
-7.88%
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Laboratory Analytical Instruments
Exchange
NASDAQ
NASDAQ
IPO
News (4w)
0
11
Recent ratings
1
21
AXDX

Accelerate Diagnostics Inc.

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was founded in 1982 and is headquartered in Tucson, Arizona.

BRKR

Bruker Corporation

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies; and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, defect-detection equipment for semiconductor process control, and spark optical emission spectroscopy systems, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments. In addition, it offers superconducting and non-superconducting materials and devices. The company serves academic and government research customers; pharmaceutical and biotechnology, diagnostics, chemical, food and beverage, clinical, nanotechnology, semiconductor, and other industrial companies; nonprofit laboratories; academic institutions and medical schools; contract research organizations; nonprofit and for-profit forensics, and environmental and clinical microbiology laboratories; agriculture, food, and beverage safety laboratories; hospitals and government departments; agencies; raw material manufacturers; and other businesses involved in materials analysis through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Latest AXDX

Latest BRKR